Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03107104 · ClinicalTrials.gov registry record
Triton Fundus Autofluorescence and Fluorescein Angiography
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 47
- Enrollment target
NCT03107104: Completed study, sponsored by Topcon Medical Systems.
NCT03107104 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03107104 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
Compare the image quality of the fundus autofluorescence and fluorescein angiography
Primary Outcome
Comparison of DRI OCT Triton (plus) and TRC-50DX photographs
Interventions
- DEVICE Topcon DRI OCT Triton (plus)
- DEVICE TRC-50DX retinal camera
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-03-30 |
| Est. Completion | 2017-09-30 |
What the finished NCT03107104 record still lists
NCT03107104 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Topcon DRI OCT Triton (plus) is the first listed.
NCT03107104 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03107104 about?
NCT03107104 is a clinical study titled "Triton Fundus Autofluorescence and Fluorescein Angiography". Compare the image quality of the fundus autofluorescence and fluorescein angiography
What is the current status of trial NCT03107104?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2017-03-30. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT03107104?
The interventions under investigation include: Topcon DRI OCT Triton (plus) (DEVICE), TRC-50DX retinal camera (DEVICE).
Who is sponsoring clinical trial NCT03107104?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI